The Frequency of Prior Antenatal Corticosteroid Therapy in Late Preterm Birth Pregnancies

ABSTRACT

We sought to quantify how often women with late preterm birth (LPTB) receive antenatal corticosteroid (ACS) therapy prior to 34 weeks and to determine its effects on neonatal respiratory morbidity. LPTBs (34⁰/₇ to 36⁶/₇ weeks) over a 1-year period at a single tertiary care hospital were studied. A composite neonatal respiratory outcome was defined as mechanical ventilation, continuous positive airway pressure with fraction of inspired oxygen (FIO ₂) >40% for >2 hours or FIO ₂ >40% for >4 hours within the first 72 hours of life. Multivariate logistic regression analysis was used to evaluate the association between ACS therapy and neonatal respiratory morbidity. Over the study period, 503 LPTBs met the study criteria and 6.8% (n = 34) had ACS therapy <34 weeks. Most had exposure >7 days prior to delivery (64.7%). Almost one-half of those receiving prior ACS therapy delivered between 34 and 35 weeks. There was no difference in the rate of prior ACS therapy based on LPTB indication for delivery. After adjusting for confounding factors, prior ACS therapy was not associated with lower respiratory morbidity (odds ratio [OR] 2.0, 95% confidence interval [CI] 0.2 to 16.3, p = 0.53). Advancing gestational age was the only variable associated with respiratory morbidity (OR 0.50, 95% CI 0.26 to .94, p = 0.03). In our population, prior ACS therapy was infrequent and was not associated with improvements in neonatal respiratory morbidity following LPTB.

KEYWORDS

Late preterm birth - preterm birth - corticosteroids - antenatal corticosteroids - neonatal respiratory morbidity

REFERENCES

• 1 Martin J A, Kirmeyer S, Osterman M, Shepherd R A. Born a bit too early: recent trends in late preterm births.  NCHS Data Brief. 2009;  24 1-8
• 2 ACOG Committee on Obstetric Practice . ACOG Committee Opinion No. 475: Antenatal corticosteroid therapy for fetal maturation.  Obstet Gynecol. 2011;  117 (2 Pt 1) 422-424
• 3 Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.  Cochrane Database Syst Rev. 2006;  3 CD004454
• 4 Clinical Trials.gov. 2011. Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial. Available at: http://clinicaltrials.gov/ct2/show/NCT01222247?term=late+preterm+birth+antenatal&rank=2 Accessed March 12, 2011
• 5 Holland M G, Refuerzo J S, Ramin S M, Saade G R, Blackwell S C. Late preterm birth: how often is it avoidable?.  Am J Obstet Gynecol. 2009;  201 404 e1-e4
• 6 Carreno C A, Costantine M M, Holland M G, Ramin S M, Saade G R, Blackwell S C. Approximately one-third of medically indicated late preterm births are complicated by fetal growth restriction.  Am J Obstet Gynecol. 2011;  204 263 e1-e4
• 7 Fuchs K SK, Gyamfi P, Gyamfi C. The effect of exposure to antenatal corticosteroids on the rate of respiratory morbidity among late preterm infants [abstract].  Am J Obstet Gynecol. 2008;  199 S44 Available at: http://download.journals.elsevierhealth.com/pdfs/journals/0002-9378/PIIS0002937808012660.pdf Accessed June 2011; 
• 8 Bastek J A, Sammel M D, Rebele E C, Srinivas S K, Elovitz M A. The effects of a preterm labor episode prior to 34 weeks are evident in late preterm outcomes, despite the administration of betamethasone.  Am J Obstet Gynecol. 2010;  203 140 e1-e7
• 9 Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation.  Am J Perinatol. 2008;  25 79-83
• 10 Ring A M, Garland J S, Stafeil B R, Carr M H, Peckman G S, Pircon R A. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.  Am J Obstet Gynecol. 2007;  196 457 e1-e6
• 11 McEvoy C, Schilling D, Spitale P, Peters D, O'Malley J, Durand M. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.  Pediatrics. 2008;  121 e1032-e1038
• 12 Peaceman A M, Bajaj K, Kumar P, Grobman W A. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes.  Am J Obstet Gynecol. 2005;  193 (3 Pt 2) 1165-1169
• 13 Stutchfield P, Whitaker R, Russell I. Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team . Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial.  BMJ. 2005;  331 662
• 14 McIntire D D, Leveno K J. Neonatal mortality and morbidity rates in late preterm births compared with births at term.  Obstet Gynecol. 2008;  111 35-41
• 15 Hibbard J U, Wilkins I, Sun L Consortium on Safe Labor et al. Respiratory morbidity in late preterm births.  JAMA. 2010;  304 419-425